Pharmaceutical

AGC and Asahi partner for clinical drug production in Seattle

AGC has entered into an agreement with Asahi Kasei to produce clinical drug substance for antibody-based therapies at its Seattle site.

Aug 16, 2023 - 20:00
AGC and Asahi partner for clinical drug production in Seattle
AGC has entered into an agreement with Asahi Kasei to produce clinical drug substance for antibody-based therapies at its Seattle site.
Read the original article

Tags:

Previous Article

Signal: Illumina under investigation by SEC over $8bn Grail acquisition

Next Article

Precision and Imugene conclude transaction for cancer drug azer-cel

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

FTC sues private equity firm Welsh Carson, U.S. Anesthesia Partners for allegedly creating a monopoly

FTC sues private equity firm Welsh Carson, U.S. Anesthe...

Sep 22, 2023

EC approves Astellas’ PADCEV for urothelial cancer

EC approves Astellas’ PADCEV for urothelial cancer

Aug 29, 2024

Eloxx repackages ELX-02 data in cystic fibrosis as it eyes pivotal trial

Eloxx repackages ELX-02 data in cystic fibrosis as it e...

Jun 15, 2023